Table 1.
Leukemia-associated antigens (LAAs) in myeloid leukemias.
| Myeloid leukemia | LAA | Reference |
|---|---|---|
| AML | Aurora-A kinase | (146, 153, 154) |
| BRAP | (160) | |
| Cyclin A1 | (161) | |
| hTert | (143) | |
| HSJ2 | (160) | |
| MPP11 | (160) | |
| Neutrophil elastase (NE) | (166) | |
| PRAME | (144, 145, 162) | |
| PR1 | (128, 139, 163, 164) | |
| Proteinase-3 | (62, 164, 165) | |
| RBPJκ | (160) | |
| RHAMM/CD168 | (142) | |
| WT1 | (62, 139, 141, 148, 149, 151, 152) | |
| CML | BRAP | (160) |
| CML-28 | (167–169) | |
| CML-66 | (167–169) | |
| HAGE | (168) | |
| HSJ2 | (160) | |
| MPP11 | (160) | |
| PRAME | (144) | |
| PR1 | (59, 139, 164, 169) | |
| Proteinase-3 | (164, 165, 169) | |
| RBPJκ | (160) | |
| Survivin | (167–169) | |
| WT1 | (139, 148, 149, 169–171) |
AML, acute myeloid leukemia; BRAP, BRCA1-associated protein; CML, chronic myeloid leukemia; HAGE, helicase antigen; HSJ2, heat-shock 40 kDa protein 4; hTert, human telomerase reverse transcriptase; MPP11, M-phase phosphoprotein 11; PRAME, preferentially expressed antigen in melanoma; RBPJκ, recombination signal binding protein for immunoglobulin kappa J region; RHAMM, receptor for hyaluronic acid-mediated motility; WT1, Wilms tumor protein.